TILLHON, Micol
TILLHON, Micol
Istituto di Genetica Molecolare "Luigi Luca Cavalli Sforza"
Assessing Cell Cycle Independent Function of the CDK Inhibitor p21(CDKN¹A) in DNA Repair
2016 Dutto I; Tillhon M; Prosperi E.
CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis
2014 Cazzalini, O; Sommatis, S; Tillhon, M; Dutto, I; Bachi, A; Rapp, A; Nardo, T; Scovassi, Ai; Necchi, D; Cardoso, Mc; Stivala, La; Prosperi, E
CBP/p300-mediated acetylation of PCNA is required for its chromatin removal and degradation in nucleotide excision repair
2014 Tillhon, M; Cazzalini, O; Sommatis, S; Dutto, I; Bachi, A; Rapp, A; Nardo, T; Scovassi, Ai; Necchi, D; Cardoso, Mc; Stivala, La; Prosperi, E
p21 regulates the affinity of PARP-1 for damaged DNA
2014 Dutto I; Tillhon M; Sukhanova MV; Cazzalini O; Stivala LA; Scovassi AI; Lavrik O; Prosperi E
ENDOGENOUS DNA DAMAGE AND DNA REPAIR DEFICIENCY IN DOWN SYNDROME FIBROBLASTS
2013 Tillhon M; Pinto A; Lanni C; Racchi M; Govoni S; Prosperi E; Necchi D
DNA damage accumulation and response in Down syndrome cell model systems
2012 Tillhon M; Necchi D; Lanni C; Scherini E; Prosperi E
2-methoxyestradiol: New perspectives in colon carcinoma treatment.
2011 Parks M; Tillhon M; Donà F; Prosperi E; Scovassi AI.
Increase in p21CDKN1A protein levels by protesome inhibitors does not affect the apoptotic response after DNA damage.
2011 Tillhon, M; Pieri, N; Cazzalini, O; Stivala, La; Scovassi, Ai; Prosperi, E
Investigating the role of p300 and CBP in Nucleotide Excision Repair: interaction with NER factors.
2010 Tillhon, M; Cazzalini, O; Nardo, T; Necchi, D; Sommatis, S; Stivala, La; Scovassi, Ai; Prosperi, E
Modulation of p21CDKN1A protein levels by anticancer agents: a double-edged sword to fight genome instability.
2010 Tillhon M; Pieri N; Cazzalini O; Stivala LA; Prosperi E.
p21(CDKN1A) participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1
2010 Cazzalini O; Donà F; Savio M; Tillhon M; Maccario C; Perucca P; Stivala LA; Scovassi AI; Prosperi E.
PARP inhibitors: new tools to protect from inflammation.
2010 Giansanti V; Dona' F; Tillhon M; Scovassi AI
Regulation of PARP-1 activity during Base Excision Repair: the role of p21CDKN1A
2010 Tillhon, M; Cazzalini, O; F Dona', F; Savio, M; Maccario, C; Perucca, P; Stivala, La; Scovassi, Ai; Prosperi, E
Pirazolcarbossiamidi e morte cellulare: una nuova arma per la chemioterapia.
2009 Giansanti, V; Camboni, T; Tillhon, M; Parks, M; Prosperi, E; Santin, G; Piscitelli, F; La Regina, G; Silvestri, R; Scovassi, Ai
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Assessing Cell Cycle Independent Function of the CDK Inhibitor p21(CDKN¹A) in DNA Repair | 1-gen-2016 | Dutto I; Tillhon M; Prosperi E. | |
| CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis | 1-gen-2014 | Cazzalini, O; Sommatis, S; Tillhon, M; Dutto, I; Bachi, A; Rapp, A; Nardo, T; Scovassi, Ai; Necchi, D; Cardoso, Mc; Stivala, La; Prosperi, E | |
| CBP/p300-mediated acetylation of PCNA is required for its chromatin removal and degradation in nucleotide excision repair | 1-gen-2014 | Tillhon, M; Cazzalini, O; Sommatis, S; Dutto, I; Bachi, A; Rapp, A; Nardo, T; Scovassi, Ai; Necchi, D; Cardoso, Mc; Stivala, La; Prosperi, E | |
| p21 regulates the affinity of PARP-1 for damaged DNA | 1-gen-2014 | Dutto I; Tillhon M; Sukhanova MV; Cazzalini O; Stivala LA; Scovassi AI; Lavrik O; Prosperi E | |
| ENDOGENOUS DNA DAMAGE AND DNA REPAIR DEFICIENCY IN DOWN SYNDROME FIBROBLASTS | 1-gen-2013 | Tillhon M; Pinto A; Lanni C; Racchi M; Govoni S; Prosperi E; Necchi D | |
| DNA damage accumulation and response in Down syndrome cell model systems | 1-gen-2012 | Tillhon M; Necchi D; Lanni C; Scherini E; Prosperi E | |
| 2-methoxyestradiol: New perspectives in colon carcinoma treatment. | 1-gen-2011 | Parks M; Tillhon M; Donà F; Prosperi E; Scovassi AI. | |
| Increase in p21CDKN1A protein levels by protesome inhibitors does not affect the apoptotic response after DNA damage. | 1-gen-2011 | Tillhon, M; Pieri, N; Cazzalini, O; Stivala, La; Scovassi, Ai; Prosperi, E | |
| Investigating the role of p300 and CBP in Nucleotide Excision Repair: interaction with NER factors. | 1-gen-2010 | Tillhon, M; Cazzalini, O; Nardo, T; Necchi, D; Sommatis, S; Stivala, La; Scovassi, Ai; Prosperi, E | |
| Modulation of p21CDKN1A protein levels by anticancer agents: a double-edged sword to fight genome instability. | 1-gen-2010 | Tillhon M; Pieri N; Cazzalini O; Stivala LA; Prosperi E. | |
| p21(CDKN1A) participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1 | 1-gen-2010 | Cazzalini O; Donà F; Savio M; Tillhon M; Maccario C; Perucca P; Stivala LA; Scovassi AI; Prosperi E. | |
| PARP inhibitors: new tools to protect from inflammation. | 1-gen-2010 | Giansanti V; Dona' F; Tillhon M; Scovassi AI | |
| Regulation of PARP-1 activity during Base Excision Repair: the role of p21CDKN1A | 1-gen-2010 | Tillhon, M; Cazzalini, O; F Dona', F; Savio, M; Maccario, C; Perucca, P; Stivala, La; Scovassi, Ai; Prosperi, E | |
| Pirazolcarbossiamidi e morte cellulare: una nuova arma per la chemioterapia. | 1-gen-2009 | Giansanti, V; Camboni, T; Tillhon, M; Parks, M; Prosperi, E; Santin, G; Piscitelli, F; La Regina, G; Silvestri, R; Scovassi, Ai |